The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
Abstract
Cytotoxic T lymphocyte (CTL) peptide epitopes can be used for immunization of mice against lethal virus infection. To study whether this approach can be successful against virus‐induced tumors we generated a B6 (H‐2 b) tumorigenic cell line transformed by human papillomavirus (HPV). This virus is detected in over 90% of all human cervical cancers. To identify vaccine candidates, we generated a set of 240 overlapping peptides derived from the HPV type 16 (HPV16) oncogenes E6 and E7. These peptides were tested for their ability to bind H‐2K b and H‐2D b MHC class I molecules. Binding peptides were compared with the presently known peptide‐binding motifs for H‐2K b and H‐2D b and the predictive value of these motifs is shortly discussed. The high‐affinity H‐2D b‐binding peptide and putative CTL epitope E 7 49‐57 (RAHYNIVTF) was used in vaccination studies against HPV 16‐transformed tumor cells. Immunization with peptide E 7 49‐57 rendered mice insensitive to a subsequent challenge with HPV 16‐transformed tumor cells in vivo, and induced a CTL response which lysed the tumor cells in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430107 · Cited by 1,666
Estimates of the worldwide frequency of sixteen major cancers in 1980
Parkin, D. M., Läärä, E., & Muir, C. S. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410205 · Cited by 1,047
Empty MHC class I molecules come out in the cold
Ljunggren, H.-G., Stam, N. J., Öhlén, C., Neefjes, J. J., Höglund, P., Heemels, M.-T., Bastin, J., Schumacher, T. N. M., Townsend, A., Kärre, K., et al. (1990) · Nature · doi:10.1038/346476a0 · Cited by 926
Baker, C. C., Phelps, W. C., Lindgren, V, Braun, M. J., Gonda, M. A., & Howley, P. M. (1987) · Journal of Virology · doi:10.1128/jvi.61.4.962-971.1987 · Cited by 757
Ozato, K., & Sachs, D. H. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.1.317 · Cited by 571
Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA
Pirisi, L., Yasumoto, S., Feller, M., Doniger, J., & DiPaolo, J. A. (1987) · Journal of Virology · doi:10.1128/jvi.61.4.1061-1066.1987 · Cited by 528
Resnick, R. M., Cornelissen, M. T. E., Wright, D. K., Eichinger, G. H., Fox, H. S., Schegget, J. T., & Manos, M. M. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.18.1477 · Cited by 452
Self-citationA molecular model of MHC class-I-restricted antigen processing
Monaco, J. J. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90122-n · Cited by 434
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro
Schumacher, T. N. M., Heemels, M.-T., Neefjes, J. J., Kast, W. M., Melief, C. J. M., & Ploegh, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90020-f · Cited by 410
Self-citationKast, W. M., Roux, L., Curren, J., Blom, H. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D., & Melief, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2283 · Cited by 326
Self-citationPierres, A., Naquet, P., Van Agthoven, A., Bekkhoucha, F., Denizot, F., Mishal, Z., Schmitt-Verhulst, A. M., & Pierres, M. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.6.2775 · Cited by 306
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes
Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., van der Eb, A. J., & Melief, C. J. M. (1989) · Cell · doi:10.1016/0092-8674(89)90006-8 · Cited by 301
Self-citationTumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60294-8 · Cited by 275
Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells
Matlashewski, G., Schneider, J., Banks, L., Jones, N., Murray, A., & Crawford, L. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02426.x · Cited by 258
Peptide selection by MHC class I molecules
Schumacher, T. N. M., De Bruijn, M. L. H., Vernie, L. N., Kast, W. M., Melief, C. J. M., Neefjes, J. J., & Ploegh, H. L. (1991) · Nature · doi:10.1038/350703a0 · Cited by 249
Self-citationHuman papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.
Chen, L. P., Thomas, E. K., Hu, S. L., Hellström, I., & Hellström, K. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.110 · Cited by 246
Brown, K., Quintanilla, M., Ramsden, M., Kerr, I. B., Young, S., & Balmain, A. (1986) · Cell · doi:10.1016/0092-8674(86)90665-3 · Cited by 245
Peptide-induced antiviral protection by cytotoxic T cells.
Schulz, M., Zinkernagel, R. M., & Hengartner, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.991 · Cited by 238
Crook, T., Morgenstern, J. P., Crawford, L., & Banks, L. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03405.x · Cited by 221
Genital papillomavirus infection and cervical dysplasia—opportunistic complications of hiv infection
Laga, M., Icenogle, J. P., Marsella, R., Manoka, A. T., Nzila, N., Ryder, R. W., Vermund, S. H., Heyward, W. L., Nelson, A., & Reeves, W. C. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500110 · Cited by 198
Tindle, R. W., Fernando, G. J., Sterling, J. C., & Frazer, I. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5887 · Cited by 167
Meneguzzi, G., Cerni, C., Kiény, M. P., & Lathe, R. (1991) · Virology · doi:10.1016/0042-6822(91)90470-v · Cited by 155
In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help
Fayolle, C., Dériaud, E., & Leclerc, C. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.12.4069 · Cited by 148
Pecoraro, G. A., Morgan, D. M., & Defendi, V. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.563 · Cited by 147
Doeberitz, M. V. K., Bauknecht, T., Bartsch, D., & Hausen, H. Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1411 · Cited by 124
Shirasawa, H., Tomita, Y., Kubota, K., KASAI, T., Sekiya, S., Takamizawa, H., & Simizu, B. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.1022-1027.1988 · Cited by 96
Bruijn, M. L. H. D., Schumacher, T. N., Nieland, J. D., Ploegh, H. L., Kast, W. M., & Melief, C. J. M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211210 · Cited by 93
Self-citationViral transcription in human keratinocyte cell lines immortalized by human papillomavirus type-16
Rohlfs, M., Winkenbach, S., Meyer, S., Rupp, T., & Dürst, M. (1991) · Virology · doi:10.1016/0042-6822(91)90146-3 · Cited by 89
Stauss, H. J., Davies, H., Sadovnikova, E., Chain, B., Horowitz, N. S., & Sinclair, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7871 · Cited by 72
Cited by
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Self-citationMelief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
Self-citationA p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Self-citation
Metadata
- Authors
- Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., De Jongh, B. M., Drijfhout, J. W., Schegget, J. T., Melief, C. J. M., & Kast, W. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1993-09
- Volume
- 23
- Issue
- 9
- Pages
- 2242-2249
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1978146796
- Cited by
- 825
- References
- 32
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.